24 related articles for article (PubMed ID: 3019548)
1. Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion.
Bernstein EA; Eberli FR; Silverman AM; Horowitz GL; Apstein CS
Cardiovasc Drugs Ther; 1996 May; 10(2):167-78. PubMed ID: 8842509
[TBL] [Abstract][Full Text] [Related]
2. Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.
Hollingshead LM; Faulds D; Fitton A
Drugs; 1992 Nov; 44(5):835-57. PubMed ID: 1280569
[TBL] [Abstract][Full Text] [Related]
3. Effects on calmodulin of bepridil, an antianginal agent.
Itoh H; Ishikawa T; Hidaka H
J Pharmacol Exp Ther; 1984 Sep; 230(3):737-41. PubMed ID: 6088765
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of calmodulin inhibitors on calmodulin's hydrophobic sites and on the activation of cyclic nucleotide phosphodiesterase by calmodulin.
Schaeffer P; Luginer C; Follenius-Wund A; Gerard D; Stoclet JC
Biochem Pharmacol; 1987 Jun; 36(12):1989-96. PubMed ID: 3036157
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of the drug-binding sites of calmodulin.
Zimmer M; Hofmann F
Eur J Biochem; 1987 Apr; 164(2):411-20. PubMed ID: 3032617
[TBL] [Abstract][Full Text] [Related]
6. Investigations on calmodulin antagonistic effects of bepridil in intact and skinned fibres of smooth muscle.
Reiermann HJ; Rüegg JC
Arzneimittelforschung; 1986 Apr; 36(4):668-70. PubMed ID: 3487326
[TBL] [Abstract][Full Text] [Related]
7. The effects of bepridil, compared with calcium-channel inhibitors and calmodulin antagonists on both spontaneous activity and contractions induced by potassium or phenylephrine in rat portal vein.
Campbell JK; Winslow E; Marshall RJ
Eur J Pharmacol; 1986 Dec; 132(2-3):187-96. PubMed ID: 3493163
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of the calmodulin antagonist bepridil on ischaemia induced in the rat myocardium.
Shikano K; Kusagawa M; Itoh H; Hidaka H
Cardiovasc Res; 1986 May; 20(5):364-8. PubMed ID: 3019548
[TBL] [Abstract][Full Text] [Related]
9. Bepridil: a pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia.
Massingham R; Van Zwieten PA
Cardiovasc Drugs Ther; 1989 Oct; 3(5):731-42. PubMed ID: 2488109
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of bepridil.
Gill A; Flaim SF; Damiano BP; Sit SP; Brannan MD
Am J Cardiol; 1992 Apr; 69(11):11D-16D. PubMed ID: 1372785
[TBL] [Abstract][Full Text] [Related]
11. Catalytic and regulatory properties of calmodulin-stimulated phosphodiesterase isozymes.
Wu Z; Sharma RK; Wang JH
Adv Second Messenger Phosphoprotein Res; 1992; 25():29-43. PubMed ID: 1313263
[No Abstract] [Full Text] [Related]
12. Targeting calmodulin in reversing multi drug resistance in cancer cells.
Mayur YC; Jagadeesh S; Thimmaiah KN
Mini Rev Med Chem; 2006 Dec; 6(12):1383-9. PubMed ID: 17168814
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
